20 Documents disponibles écrits par cet auteur
This briefing discusses the evidence supporting the theory that most drug misusers will mature out of their drug use albeit after many years in some cases while recognising there will be a number of problem users who, from choice or circumstan[...]
E. DAY ; A. COPELLO ; M. HULL | 2015
Dans British Medical Journal (Vol.350, n°7996, 21 February 2015) Article : PériodiqueAlcohol can impact on both the incidence and the course of many health conditions, and nearly 6% of all global deaths in 2012 were estimated to be attributable to its consumption. A quarter of the UK adult population drinks alcohol in a way that[...]
D. BEST ; J. SEGAL ; E. DAY | 2009
Dans Journal of Substance Use (Vol.14 n°2, 2009) Article : PériodiqueENGLISH : The publication of Hidden Harm [Advisory Counsil on the Misuse of Drugs (ACMD), 2003] was an attempt to increase awareness of the risks to children of parental drug use, and the need for a coherent response across services to this is[...]
E. DAY ; D. BEST ; A. COPELLO ; H. YOUNG ; KHOOSAL N. ; MODERN N. | 2008
Dans Journal of Substance Use (Vol.13 n°1, 2008) Article : PériodiqueENGLISH : Background: The expansion of drug treatment services has outstripped the capacity of specialist prescribers in the UK, and GPs have increasingly been recruited as prescribers of substitution therapies. Local circumstances have usuall[...]![Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures? [For debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_77057.webp?v=1771280896)
J. STRANG ; R. McDONALD ; B. TAS ; E. DAY | 2016
Dans Addiction (Vol.111, n°4, April 2016) Article : PériodiqueContext: Take-home naloxone is increasingly provided to prevent heroin overdose deaths. Naloxone 0.4-2.0 mg is licensed for use by injection. Some clinicians supply improvised nasal naloxone kits (outside lisenced approval). Is this acceptable? [...]
B. NOSYK ; H. SUN ; E. EVANS ; D. C. MARSH ; M. D. ANGLIN ; Y. I. HSER ; A. H. ANIS ; E. DAY, Auteur du commentaire | 2012
Dans Addiction (Vol.107, n°9, September 2012) Article : PériodiqueAims: To identify dose-tapering strategies associated with sustained success following methadone maintenance treatment (MMT). Design: Population-based retrospective cohort study. Setting: Linked administrative medication dispensation data fr[...]
ENGLISH : Aims: To compare the motivation for and process of attempting self detoxification from opioid drugs between White and Asian groups attending a drug-treatment service. Method: Eighty-nine clients (41 Asians, 48 Whites) attending a com[...]
K. M. BOGDANOWICZ ; R. STEWART ; C. K. CHANG ; H. SHETTY ; M. KHONDOKER ; E. DAY ; R. D. HAYES ; J. STRANG | 2018
Dans Addiction (Vol.113, n°5, May 2018) Article : PériodiqueAIMS: To investigate clustering of all-cause and overdose deaths after a transfer of patients and their care to alternative treatment provider and after the end of opioid substitution therapy (OST) in opioid-dependent individuals in specialist a[...]
N. LOWRY ; A. MCKECHNIE ; E. DAY ; E. GILVARRY ; F. COWDEN ; R. EVANS ; R. LOCKE ; R. MURRAY ; R. VANDERWAAL ; S. JOHNSTONE ; Z. HOARE ; M. KELLEHER ; L. MITCHESON ; J. MARSDEN | 2025
Dans Addiction (Vol.120, n°10, October 2025) Article : PériodiqueBACKGROUND AND AIMS: An investigation of 24 weeks of extended-release buprenorphine (BUP-XR; Sublocade®) treatment for adults with opioid use disorder (OUD). Study aims were to characterise variations in clinical response, investigate personal f[...]
J. ORFORD ; S. BOULAY ; A. COPELLO ; N. GRAVES ; B. PURSER ; E. DAY | 2003
Dans International Gambling Studies (Vol.3, n°2, 2003) Article : PériodiqueA self-completion questionnaire containing items about recent gambling and problem gambling used in the British Gambling Prevalence Survey (BGPS) was completed by 274 clients of alcohol and drug problems services in the English West Midlands. Co[...]
E. DAY ; ISON J. ; J. STRANG | 2005
Dans Cochrane Database of Systematic Reviews (n°2, 2005) Article : PériodiqueBACKGROUND: There are a complex range of variables that can influence the course and subjective severity of opioid withdrawal. There is a growing evidence for the effectiveness of a range of medically-supported detoxification strategies, but lit[...]
M. CONNOCK ; A. JUAREZ-GARCIA ; S. JOWETT ; E. FREW ; Z. LIU ; R. J. TAYLOR ; A. FRY-SMITH ; E. DAY ; N. LINTZERIS ; T. ROBERTS ; A. BURLS ; R. S. TAYLOR | 2007
Dans Health Technology Assessment (Vol.11 n°9, 2007) Article : PériodiqueBackground: Opiate dependence is becoming increasingly prevalent, with associated increases in the spread of infectious disease (e.g. HIV, hepatitis B and C) and overdose deaths. Methadone has traditionally been the mainstay drug used in the man[...]![Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs [Commentary]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_81939.webp?v=1771301634)
E. DAY ; T. BRODER ; J. BRUNEAU ; S. CRUSE ; M. DICKIE ; S. FISH ; C. GRILLON ; N. LUHMANN ; K. MASON ; E. MCLEAN ; S. TROOSKIN ; C. TRELOAR ; J. GREBELY | 2019
Dans International Journal of Drug Policy (Vol.66, April 2019) Article : PériodiqueIt is estimated that 6.1 million people with recent injecting drug use (PWID) are living with hepatitis C virus (HCV). Although HCV-related morbidity and mortality among PWID continues to increase, the advent of direct acting antiviral (DAA) HCV[...]
R. CHATTERS ; K. COOPER ; E. DAY ; M. KNIGHT ; O. LAGUNDOYE ; R. WONG ; E. KALTENTHALER | 2016
Dans Addiction Research and Theory (Vol.24, n°2, April 2016) Article : PériodiqueObjective: Many psychological and psychosocial interventions have been developed to treat regular users of cannabis, but it is unclear which intervention(s) are the most effective. This article aims to assess the effectiveness of psychological a[...]![Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism? [Addiction debate]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_79165.webp?v=1771252913)
E. DAY, Auteur ; L. MITCHESON, Auteur ; P. M. FLYNN, Auteur du commentaire ; C. J. STRIKE ; A. GUTA ; J. SELIN ; D. RAISTRICK ; E. DAY ; L. MITCHESON, Auteur du commentaire | 2017
Dans Addiction (Vol.112, n°8, August 2017) Article : PériodiqueBackground and Aims: Clinical guidelines from around the world recommend the delivery of psychosocial interventions as part of routine care in opiate substitution treatment (OST) programmes. However, although individual studies demonstrate benef[...]
Historique
